Tumour cells resistance in cancer therapy

Isabel Martínez-Lacaci; Pilar GarcÍa Morales; Jos É Luis Soto; Miguel Saceda

doi:10.1007/s12094-007-0004-9

Tumour cells resistance in cancer therapy

Isabel Martínez-Lacaci, Pilar GarcÍa Morales, Jos É Luis Soto, Miguel Saceda

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

31 Citas (Scopus)

Resumen

Resistance to chemotherapeutic drugs presents a big caveat for cancer treatment. In this review we will describe the molecular mechanisms involved in chemoresistance, discussing the mechanisms of resistance related to tumour microenvironment, as well as their intracellular mechanisms. Chemoresistance can also appear as a consequence to treatments with new anticancer drugs. In this sense, we will exemplify this type of resistance discussing mechanisms of action of epidermal growth factor receptor (EGFR) inhibitors. We conclude that the main problem of chemoresistance is due to its pleiotropic and multifactorial nature.

Idioma original	Inglés
Páginas (desde-hasta)	13-20
Número de páginas	8
Publicación	Clinical and Translational Oncology
Volumen	9
N.º	1
DOI	https://doi.org/10.1007/s12094-007-0004-9
Estado	Publicada - 2007
Publicado de forma externa	Sí

Acceder al documento

10.1007/s12094-007-0004-9

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{4b9cc552f9e2492dbacd8e047d6f3967,

title = "Tumour cells resistance in cancer therapy",

abstract = "Resistance to chemotherapeutic drugs presents a big caveat for cancer treatment. In this review we will describe the molecular mechanisms involved in chemoresistance, discussing the mechanisms of resistance related to tumour microenvironment, as well as their intracellular mechanisms. Chemoresistance can also appear as a consequence to treatments with new anticancer drugs. In this sense, we will exemplify this type of resistance discussing mechanisms of action of epidermal growth factor receptor (EGFR) inhibitors. We conclude that the main problem of chemoresistance is due to its pleiotropic and multifactorial nature.",

keywords = "Apoptosis, Chemoresistance, MDR",

author = "Isabel Mart{\'i}nez-Lacaci and {Garc{\'I}a Morales}, Pilar and Soto, {Jos {\'E} Luis} and Miguel Saceda",

note = "Funding Information: *Supported by an unrestricted educational grant from Pfizer.",

year = "2007",

doi = "10.1007/s12094-007-0004-9",

language = "Ingl{\'e}s",

volume = "9",

pages = "13--20",

journal = "Clinical and Translational Oncology",

issn = "1699-048X",

publisher = "Springer-Verlag Italia",

number = "1",

}

TY - JOUR

T1 - Tumour cells resistance in cancer therapy

AU - Martínez-Lacaci, Isabel

AU - GarcÍa Morales, Pilar

AU - Soto, Jos É Luis

AU - Saceda, Miguel

N1 - Funding Information: *Supported by an unrestricted educational grant from Pfizer.

PY - 2007

Y1 - 2007

N2 - Resistance to chemotherapeutic drugs presents a big caveat for cancer treatment. In this review we will describe the molecular mechanisms involved in chemoresistance, discussing the mechanisms of resistance related to tumour microenvironment, as well as their intracellular mechanisms. Chemoresistance can also appear as a consequence to treatments with new anticancer drugs. In this sense, we will exemplify this type of resistance discussing mechanisms of action of epidermal growth factor receptor (EGFR) inhibitors. We conclude that the main problem of chemoresistance is due to its pleiotropic and multifactorial nature.

AB - Resistance to chemotherapeutic drugs presents a big caveat for cancer treatment. In this review we will describe the molecular mechanisms involved in chemoresistance, discussing the mechanisms of resistance related to tumour microenvironment, as well as their intracellular mechanisms. Chemoresistance can also appear as a consequence to treatments with new anticancer drugs. In this sense, we will exemplify this type of resistance discussing mechanisms of action of epidermal growth factor receptor (EGFR) inhibitors. We conclude that the main problem of chemoresistance is due to its pleiotropic and multifactorial nature.

KW - Apoptosis

KW - Chemoresistance

KW - MDR

UR - http://www.scopus.com/inward/record.url?scp=34249021632&partnerID=8YFLogxK

U2 - 10.1007/s12094-007-0004-9

DO - 10.1007/s12094-007-0004-9

M3 - Artículo

C2 - 17272225

AN - SCOPUS:34249021632

SN - 1699-048X

VL - 9

SP - 13

EP - 20

JO - Clinical and Translational Oncology

JF - Clinical and Translational Oncology

IS - 1

ER -

Tumour cells resistance in cancer therapy

Resumen

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto